Whole-exome sequencing studies of nonfunctioning pituitary adenomas

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 4, 2013, Pages

  Newey, Paul J ^a   Nesbit, M Andrew ^a   Rimmer, Andrew J ^b   Head, Rosie A ^a   Gorvin, Caroline M ^a   Attar, Moustafa ^b   Gregory, Lorna ^b   Wass, John A H ^c   Buck, David ^b   Karavitaki, Niki ^c   Grossman, Ashley B ^c   McVean, Gilean ^b   Ansorge, Olaf ^d   Thakker, Rajesh V ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^d JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIDEOXYNUCLEOTIDE; DNA; MYC PROTEIN; N MYC DOWN REGULATED GENE FAMILY MEMBER 4 PROTEIN; PLATELET DERIVED GROWTH FACTOR D; PROTEIN KINASE; UNCLASSIFIED DRUG; ZIPPER STERILE ALPHA MOTIF KINASE;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; DOWN REGULATION; EXOME; FEMALE; FRAMESHIFT MUTATION; GENE DELETION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC IDENTIFICATION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; LEUKOCYTE; MALE; MISSENSE MUTATION; NDRG4 GENE; NONFUNCTIONING PITUITARY ADENOMA; PDGFD GENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC CELL GENETICS; WHOLE GENOME SEQUENCING; ZAK GENE;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; DNA MUTATIONAL ANALYSIS; EXOME; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; MUTATION; PITUITARY NEOPLASMS; SEQUENCE ANALYSIS, DNA; TRANSCRIPTOME;

EID: 84876233094     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-4028     Document Type: Article

References (20)

1. Melmed S. Pathogenesis of pituitary tumors. Nat Rev Endocrinol. 2011; 7:257-266.
2. Fernandez A, Karavitaki N, Wass JAH. Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol (Oxf). 2010; 72:377-382.
3. Wass JAH, Karavitaki N. Nonfunctioning pituitary adenomas: the Oxford experience. Nat Rev Endocrinol. 2009; 5:519-522.
4. Herman V, Fagin J, Gonsky R., Kovacs K, Melmed S. Clonal origin of pituitary adenomas. J Clin Endocrinol Metab. 1990; 71:1427-1433.
5. Vandeva S, Jaffrain-Rea ML, Daly A.F., Tichomirowa M., Zacharieva S, Beckers A. The genetics of pituitary adenomas. Best Pract Res Clin Endocrinol Metab. 2010; 24:461-476.
6. Dworakowska D, Grossman AB The pathophysiology of pituitary adenomas. Best Pract Res Clin Endocrinol Metab. 2009; 23:525-541.
7. Elston MS, McDonald KL, Clifton-Bligh RJ, Robinson BG Familial pituitary tumor syndromes. Nat Rev Endocrinol. 2009; 5: 453-461.
8. Ruggeri RM, Santarpia L, Curto L., et al Non-functioning pituitary adenomas infrequently harbor G-protein gene mutations. J Endocrinol Invest. 2008; 31:946-949.
9. Jiao Y, Shi C, Edil B.H., et al DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science. 2011; 331:1199-1203.
10. Newey PJ, Nesbit MA, Rimmer A.J., et al Whole-exome sequencing studies of nonhereditary (sporadic) parathyroid adenomas. J Clin Endocrinol Metab. 2012; 97:E1995-E2005.
11. Cromer MK, Starker LF, Choi M, et al Identification of somatic mutations in parathyroid tumors using whole-exome sequencing. J Clin Endocrinol Metab. 2012; 97:E1774-E1781.
12. Stratton MR. Exploring the genomes of cancer cells: progress and promise. Science. 2011; 331:1553-1558.
13. Wang Z, Ahmad A, Li Y., et al Emerging roles of PDGF-D signaling pathway in tumor development and progression. Biochim Biophys Acta. 2010; 1806:122-130.
14. Schilling SH, Hjelmeland AB, Radiloff D.R., et al NDRG4 is required for cell cycle progression and survival in glioblastoma cells. J Biol Chem. 2009; 284:25160-25169.
15. Melotte V, Lentjes MH, van den Bosch SM, et al. N-myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer. J Natl Cancer Inst. 2009; 101:916-927.
16. Yang JJ, Lee YJ, Hung H.H., et al ZAK inhibits human lung cancer cell growthvia ERK and JNK activationinanAP-1-dependent manner. Cancer Sci. 2010; 101:1374-1381.
17. Liu P, Morrison C, Wang L., et al Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing. Carcinogenesis. 2012; 33:1270-1276.
18. Wang K, Kan J, Yuen S.T., et al Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer. Nat Genet. 2011; 43:1219-1223.
19. Wang L, Lawrence MS, Wan Y, et al SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med. 2011; 365: 2497-2506.
20. Duong CV, Emes RD, Wessely F, Yacqub-Usman K, Clayton R.N., Farrell WE Quantitative, genome-wide analysis of the DNA methy-lome in sporadic pituitary adenomas. Endocr Relat Cancer. 2012; 19:805-816.